Latest Insider Transactions at Marker Therapeutics, Inc. (MRKR)
This section provides a real-time view of insider transactions for Marker Therapeutics, Inc. (MRKR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Marker Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Marker Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2024
|
New Enterprise Associates 16, L.P. |
BUY
Open market or private purchase
|
Direct |
554,250
+25.43%
|
$1,662,750
$3.2 P/Share
|
|
Mar 24
2022
|
Anthony H. Kim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
36,076
-23.97%
|
$0
$0.48 P/Share
|
|
Mar 24
2022
|
Anthony H. Kim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,512
+50.0%
|
-
|
|
Mar 24
2022
|
Juan Vera President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
33,465
-1.24%
|
$0
$0.48 P/Share
|
|
Mar 24
2022
|
Juan Vera President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
140,823
+4.95%
|
-
|
|
Mar 24
2022
|
Peter L. Hoang President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
48,376
-9.1%
|
$0
$0.48 P/Share
|
|
Mar 24
2022
|
Peter L. Hoang President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
199,094
+27.24%
|
-
|
|
Jun 08
2021
|
John Robert Wilson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,658
+0.16%
|
-
|
|
Jun 08
2021
|
Norman David Eansor Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,658
+25.52%
|
-
|
|
Jun 08
2021
|
Steve Elms Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,658
+29.9%
|
-
|
|
Jun 08
2021
|
David Laskow Pooley Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,658
+18.65%
|
-
|
|
Jun 08
2021
|
Frederick Gerald Wasserman Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,658
+16.25%
|
-
|
|
May 18
2021
|
Frederick Gerald Wasserman Director |
BUY
Open market or private purchase
|
Direct |
10,000
+15.98%
|
$20,000
$2.41 P/Share
|
|
Mar 25
2021
|
Norman David Eansor Director |
BUY
Bona fide gift
|
Indirect |
14,284
+50.0%
|
-
|
|
Mar 25
2021
|
Norman David Eansor Director |
SELL
Bona fide gift
|
Direct |
14,285
-85.47%
|
-
|
|
Mar 16
2021
|
Norman David Eansor Director |
BUY
Open market or private purchase
|
Direct |
14,285
+46.08%
|
$242,845
$17.5 P/Share
|
|
Mar 16
2021
|
Steve Elms Director |
BUY
Open market or private purchase
|
Indirect |
1,142,857
+26.67%
|
$1,142,857
$1.75 P/Share
|
|
Mar 16
2021
|
Peter L. Hoang President and CEO |
BUY
Open market or private purchase
|
Direct |
142,857
+30.05%
|
$142,857
$1.75 P/Share
|
|
Mar 16
2021
|
Juan Vera President and CEO |
BUY
Open market or private purchase
|
Direct |
571,428
+18.22%
|
$571,428
$1.75 P/Share
|
|
Mar 16
2021
|
John Robert Wilson Director |
BUY
Open market or private purchase
|
Direct |
1,714,285
+18.02%
|
$1,714,285
$1.75 P/Share
|
|
Mar 16
2021
|
New Enterprise Associates 16, L.P. |
BUY
Open market or private purchase
|
Direct |
5,714,285
+34.78%
|
$5,714,285
$1.75 P/Share
|
|
Mar 16
2021
|
Forest Baskett > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,714,285
+34.78%
|
$5,714,285
$1.75 P/Share
|
|
Mar 16
2021
|
Ali Behbahani > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,714,285
+34.78%
|
$5,714,285
$1.75 P/Share
|
|
Mar 16
2021
|
Carmen Chang > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,714,285
+34.78%
|
$5,714,285
$1.75 P/Share
|
|
Mar 16
2021
|
Anthony A. Florence Jr. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,714,285
+34.78%
|
$5,714,285
$1.75 P/Share
|
|
Mar 16
2021
|
Mohamad Makhzoumi > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,714,285
+34.78%
|
$5,714,285
$1.75 P/Share
|
|
Mar 16
2021
|
Joshua Makower > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,714,285
+34.78%
|
$5,714,285
$1.75 P/Share
|
|
Mar 16
2021
|
Scott D Sandell > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,714,285
+34.78%
|
$5,714,285
$1.75 P/Share
|
|
Mar 16
2021
|
Peter W. Sonsini > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,714,285
+34.78%
|
$5,714,285
$1.75 P/Share
|
|
Mar 16
2021
|
Paul Edward Walker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,714,285
+34.78%
|
$5,714,285
$1.75 P/Share
|